English | Español

Regulatory
+ Regulatory
Patient Daily | Dec 8, 2025

Sen. Crapo on bipartisan PBM transparency act: 'Pharmacy benefit managers should not profit from overcharging patients'
+ Regulatory
Patient Daily | Nov 6, 2025

Executive Director of Patients Come First on lawsuit ads: ‘One of the most pervasive and least regulated forces in consumer media’
+ Regulatory
Patient Daily | Nov 5, 2025

Bliksem Health founder: 'The 340B drug program was supposed to help poor patients'
+ Regulatory
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on 340B program: 'Providers are increasingly abusing 340B'
+ Regulatory
Patient Daily | Oct 16, 2025

USC Schaeffer Center Senior Fellow: 340B spread pricing 'makes healthcare more expensive'
+ Regulatory
Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact
+ Regulatory
Patient Daily | Oct 14, 2025

Delaware federal court dismisses Eli Lilly lawsuit against Strive Pharmacy
+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes